Alvin is a research fellow at the University of Sydney with a background in pharmacy and public health. His interests include global health, tuberculosis epidemiology and control in high-burden settings and operational research to support programmes and inform policy-making. Much of his work is carried out in Cambodia and Vietnam.
Levofloxacin was safe for MDR-TB contacts, with very few adverse events greater than or equal to grade 3 reported. Most adverse events were mild to moderate, and musculoskeletal events were the most common. Close follow-up during the first month of treatment is crucial to monitor and manage any adverse events promptly. Further research evaluating strategies to minimise musculoskeletal symptoms may improve treatment adherence and completion rates.
Source: Conference 2024